Evidence map›Paper›PMID 21290237›Full record

ReviewHandbook of experimental pharmacology2011

Neuropeptides in lower urinary tract function.

Lauren Arms, Margaret A Vizzard

Abstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Protective Effects of PACAP in Peripheral Organs.Frontiers in endocrinology · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lauren ArmsDepartment of Anatomy and Neurobiology, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Margaret A Vizzard
University of Vermont · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MARTIN-CARABALLO, MIGUEL · 2001 to 2010
$23.5M
Cystitis-Induced Plasticity of Micturition ReflexesR01DK051369 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2003 to 2017
$5.4M
Developmental Plasticity of Micturition ReflexesR01DK060481 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2002 to 2018
$4.5M
Neurotrophic Mechanisms in LUT Plasticity with CystitisR01DK065989 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2003 to 2007
$1.4M
Developmental plasticity of micturation reflexesR56DK060481 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2008 to 2008
$232k
IRRITATION INDUCED PLASTICITY OF MICTURITION PATHWAYSR29DK051369 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 1996 to 2000
$109k
NCRR NIH HHS P20 RR016435NCRR NIH HHS P20 RR16435NIDDK NIH HHS DK051369NIDDK NIH HHS DK060481NIDDK NIH HHS DK065989NIDDK NIH HHS R01 DK051369NIDDK NIH HHS R01 DK060481NIDDK NIH HHS R01 DK065989NIDDK NIH HHS R29 DK051369NIDDK NIH HHS R56 DK060481
6 · The paper itself

Abstract

Numerous neuropeptide/receptor systems including vasoactive intestinal polypeptide, pituitary adenylate cyclase-activating polypeptide, calcitonin gene-related peptide, substance P, neurokinin A, bradykinin, and endothelin-1 are expressed in the lower urinary tract (LUT) in both neural and nonneural (e.g., urothelium) components. LUT neuropeptide immunoreactivity is present in afferent and autonomic efferent neurons innervating the bladder and urethra and in the urothelium of the urinary bladder. Neuropeptides have tissue-specific distributions and functions in the LUT and exhibit neuroplastic changes in expression and function with LUT dysfunction following neural injury, inflammation, and disease. LUT dysfunction with abnormal voiding, including urinary urgency, increased voiding frequency, nocturia, urinary incontinence, and pain, may reflect a change in the balance of neuropeptides in bladder reflex pathways. LUT neuropeptide/receptor systems may represent potential targets for therapeutic intervention.

Indexed as

Signal TransductionUrinationAnimalsBradykininCalcitonin Gene-Related PeptideEndothelinsHumansNeural PathwaysNeuropeptidesPituitary Adenylate Cyclase-Activating PolypeptideReceptors, NeuropeptideReflexSubstance PTachykininsUrinary TractUrologic DiseasesBradykininCalcitonin Gene-Related PeptideEndothelinsNeuropeptidesPituitary Adenylate Cyclase-Activating PolypeptideReceptors, NeuropeptideSubstance PTachykininsVasoactive Intestinal Peptide

Identifiers

PMID21290237
PMCPMC4040464
OpenAlexW68278331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.